Azitra, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AZTR NYSE American 2830 azitrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Azitra, Inc.

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - May 14th, 2025 8:05 pm
Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - May 13th, 2025 9:06 pm
Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 - Apr 25th, 2025 12:33 pm
Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline - Apr 24th, 2025 8:05 pm
Azitra to Present at Microbiome Times Partnering Forum - Mar 12th, 2025 12:33 pm
AZTR: Netherton Topline Expected by Year-End - Mar 3rd, 2025 9:39 am
Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates - Feb 24th, 2025 1:30 pm
Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock - Feb 4th, 2025 7:20 pm
Azitra, Inc. to Present at the BIO CEO & Investor Conference - Feb 3rd, 2025 2:05 pm
Azitra, Inc. to Present at The Microcap Conference - Jan 27th, 2025 9:05 pm
Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock - Jan 15th, 2025 1:30 pm
Azitra Announces Proposed Public Offering of Common Stock - Jan 14th, 2025 9:05 pm
AZTR: Planning 2nd Site for ATR-12 Trial - Nov 15th, 2024 3:14 pm
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates - Nov 12th, 2024 10:05 pm
Azitra to Present at BIO-Europe 2024 - Oct 29th, 2024 1:00 pm
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 11th, 2024 1:00 pm
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress - Sep 24th, 2024 12:00 pm
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors - Sep 18th, 2024 1:00 pm
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Sep 6th, 2024 8:30 pm
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome - Aug 28th, 2024 12:30 pm